Australian Biotechnology News

Stories about: Royal Melbourne Hospital

  • +

    First cannabis-based drug approved in Europe 25/06/2010 00:05:00

    The first cannabis-based pharmaceutical product has been approved in the UK, paving the way for widespread adoption throughout Europe.
  • +

    Bone union for Mesoblast 06/08/2008 11:33:02

    Patients achieve bone union in long-time non-healing bones after implantation of Mesoblast's adult stem cells
  • +

    This week in Oz biotech 18/04/2008 13:33:34

    Eastland's under the tongue, Bionomics disrupts further, Novogen adds on and Mesoblast's arthritic sheep.
  • +

    Bionomics begins Phase 1 trial 27/02/2008 11:46:24

    The first patients have begun treatment in Bionomics' Phase 1 trial of its vascular disruption agent.
  • +

    Proteomics for cancer diagnostics 18/12/2007 11:00:13

    Genomics is old hat and proteomics is now where it's at, according to Richard Christopherson.
  • +

    Boning up on mesenchymal stem cells 16/10/2007 10:43:00

    As it begins Phase IIa clinical trials, Mesoblast is riding high: its share price is climbing, its market capitalisation is booming and all that promise seems to be coming good.
  • +

    Bone repair trial yields growth 22/06/2007 13:50:59

    Mesoblast announces strong interim results in fracture repair trial.
  • +

    BioPharmica to offer IPO 14/06/2007 11:34:26

    BioPharmica intends to offer an IPO on one of its spin-off companies, Cortical Dynamics.
  • +

    Mesoblast implants two with adult stem cells 06/02/2006 14:40:21

    The first two patients in Melbourne-based Mesoblast's (ASX:MSB) clinical trials have been implanted with adult stem cells.
  • +

    BioPharmica aims to raise $2.5m 13/01/2006 15:19:39

    Perth based BioPharmica (ASX:BPH) has opened a share purchase plan to raise AUD$2.5 million to fund the development of its portfolio of biomedical research.
  • +

    First patients recruited in Mesoblast stem cell trials 08/12/2005 09:21:49

    The first few patients have been formally recruited for two pilot clinical trials of Melbourne-based Mesoblast's (ASX:MSB) adult stem cell platform technology.
Additional Resources
Newsletter Subscription
Sign up for our Australian Life Scientist newsletters!
 
Jobs